A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

Summer is a busy time, it’s filled with vacations, outdoor activities, and family events that can easily distract us from ...

Up to 80% of women have them during their reproductive years. Around half of them struggle with symptoms that cause ...

The combination of toripalimab, nimotuzumab, and chemotherapy showed “promising antitumor activity with acceptable toxicity,” researchers wrote.

Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...

Dana Coolwell’s U.S. adventure resulted in back-to-back-defeats and now a lengthy suspension following a positive drug test, ...

After four years of searching for a bone marrow donor, a Richmond family will finally get the procedure needed to cure their ...

Several other medical conditions can mimic the symptoms of low testosterone, including depression, sleep apnea, ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...